Skip to content

Treatment of Irreducible Atlantoaxial Dislocation Using the direct posterior comprehensive reduction approach Technique and traditional Occipitocervical fusion technique

Treatment of Irreducible Atlantoaxial Dislocation Using the direct posterior comprehensive reduction approach Technique and traditional Occipitocervical fusion technique

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016616
Enrollment
Unknown
Registered
2018-06-12
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irreducible Atlantoaxial Dislocation

Interventions

Direct posterior comprehensive reduction approach surgery Group:Underwent Direct posterior comprehensive reduction approach surgery
Traditional Ocipitocervical fusion surgery Group:Underwent Traditional Ocipitocervical fusion surgery
Posterior reduction combined with anterior release of the cervicomedullary junction:Anterior approach was used routinely to release the cervicomedullary junction before posterior fusion and stabilizat

Sponsors

Changzheng Hospital, Second Militrary Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) patients aged 10-70 years, without gender limitation, are willing to sign informed consent; 2) patients diagnosed with irreducible atlantoaxial dislocation; 3) patients with limbs numbness, walking instability, or other spinal cord, nerve root compression symptoms, may be associated with irreducible atlantoaxial dislocation, conservative treatment is invalid or gradually increased; 4) There was no significant reduction in atlantoaxial dislocation after 1-3 weeks of preoperative traction.

Exclusion criteria

Exclusion criteria: 1) Cervical ligamentous ossification, cervical trauma, cervical cancer, cervical tuberculosis and other inflammatory diseases; 2) accompanied by other spine parts of the disease affect the clinical symptoms of patients; 3) associated with amyotrophic lateral sclerosis and other motor neuron diseases and other neurological diseases; 4) poor health condition, unable to tolerate surgery; 5) patients (or their guardians) can not give full informed consent for adult dysfunction; 6) patients who have participated in other clinical trials in the past 1 month; 7) patients with active hepatitis B (including HBeAg) or serological markers (HBsAg or/and HBeAg or/and HBcAb), hepatitis C, tuberculosis, cytomegalovirus infection, severe fungal infection , HIV infection or patients with Turmor.

Design outcomes

Primary

MeasureTime frame
JOA score;

Secondary

MeasureTime frame
NURIC;Visual Analogue Scale/Score(VAS);Radiological parameters;

Countries

China

Contacts

Public ContactGuohua Xu

Department of Orthopaedic Surgery, The spine surgical center, Changzheng Hospital, Second Militrary Medical University

xuguohuamail@smmu.edu.cn+86 13386279098

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026